"Hospitals in the U.S. continue to make progress in the fight against central line-associated bloodstream infections and some surgical site infections, according to a report issued today by the Centers for Disease Control and Prevention (CDC). "...
This drug is contraindicated in persons with a prior history of hypersensitivity reactions to polymyxins.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/10/2008
Additional Polymyxin B Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.